A comparative physicochemical and pharmacological evaluation of dexamethasone sodium phosphate and betamethasone sodium phosphate mucoadhesive gels for the treatment of oral submucous fibrosis in rats

Authors

  • Vijaybhaskar Desai Dept. of Pharmaceutics, HKES’s Matoshree Taradevi Rampure Institute of Pharmaceutical Sciences Kalaburagi, Karnataka, India https://orcid.org/0000-0002-5138-9680
  • Sidramappa Shirsand Dept. of Pharmaceutics, HKES’s Matoshree Taradevi Rampure Institute of Pharmaceutical Sciences Kalaburagi, Karnataka, India
  • Gurunath Surampalli Bharat Institute of Technology-Pharmacy, Dept. of Pharmacology, Hyderabad, Telangana, India

DOI:

https://doi.org/10.1590/s2175-97902022e20262%20%20

Keywords:

Oral submucous fibrosis (OSMF), Carboyxmethyl cellulose sodium (Na CMC), Hydroxypropyl methyl cellulose (HPMC), Dexamethasone sodium phosphate (DSP)

Abstract

The present study is aimed to formulate steroidal oral mucoadhesive gels of dexamethasone sodium phosphate and betamethasone sodium phosphate. Six gel formulations each of dexamethasone sodium phosphate and betamethasone sodium phosphate prepared using two different polymers carboxymethyl cellulose sodium and hydroxypropyl methylcellulose, in variable proportions. All the formulations subjected for assessment of various physicochemical parameters and mechanical properties. The formulations BSP5 and DSP5, both containing 1.25 % carboxymethyl cellulose sodium, 1.25 % hydroxypropyl methylcellulose, exhibiting mucoadhesive strength of 12.300 ± 0.004 and 12.600 ± 0.01, adhesiveness of 28.04 ± 00 and 30.02 ± 00, cohesiveness of 28.04 ± 00 and 30.02 ± 00, drug release of 86.869 ± 0.380 % and 88.473 ± 0.457 % respectively were considered as promising ones and were further subjected for stability studies and in vivo study in male albino rats. Formulation DSP5 upon oral application for 4 months in arecoline induced oral submucous fibrosis rats, showed more than 80 % reduction in fibrosis as compared with BSP5 which showed nearly 50 % reduction. These results were concluded on the basis of histopathological profile and weight gain among the experimental animals during in vivo study. Hence, DSP5 by minimizing the painful injuries and morbidities justifies being suitable noninvasive model for OSMF treatment.

Downloads

Download data is not yet available.

References

Ahuja A, Khar RK, Ali J. Mucoadhesive drug delivery system. Drug Dev Ind Pharm. 1997;23(5):489-515.

Ali FM, Patil A, Patil K, Prasant MC. Oral submucous fibrosis and its dermatological relation. Indian Dermatol Online J. 2014;5(3):260-65.

Amasya G, Karvana SY, Sen T, Baloglo E, Tarimci N. Bioadhesive and mechanical properties of triamcinolone acetonide buccal gels. J Pharm Sci. 2012;9(1):1-12.

Angadi PV, Rao SS. Areca nut in pathogenesis of oral submucous fibrosis: revisited. Oral Maxillofac Surg. 2011;15(1):1-9.

Arakeri G, Brennan AP. Oral submucous fibrosis: an overview of aetiology, pathogenesis, classification and principles of management. Br J Oral Maxillofac Surg . 2013;51(7):587-93.

Aslani A, Melekpour N. Design, formulation and physicochemical evaluation of periodontal propolis mucoadhesive gels. Dent Res J. 2016;13(6):484-93.

Aslani A, Zolfaghari B, Fereidani Y. Design, formulation and evaluation of herbal gel contains melissa, sumac, licorice, rosemary and geranium for treatment of recurrent labial herpes infections. Dent Res J. 2018;15(3):191-200.

Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotech Ann Rev. 2005;11:127-52.

Bhatia HB, Sachan A, Bhandari A. Studies on thermoreversive mucoadhesive ophthalmic in situ gel of azithromycin. J Drug Discov Ther. 2013;3(5):106-9.

Boddupalli BM, Mohammed ZNK, Nath RA, Banji D. Mucoadhesive drug delivery system: A overview. J Adv Pharm Technol Res. 2010;1(4):381-87.

Betamethasone sodium phosphate. British Pharmacopoeia. Volume 3. London: The stationary office; 2008. p. 3287.

Chen X, Yan J, Shuying YU, Wang P. Formulation and in vitro release kinetics of mucoadhesive blend gels containing matrine for buccal administration. AAPS Pharm Sci Tech. 2018;19(1):470-80.

Dexamethasone sodium phosphate. British Pharmacopoeia. Volume 3. London: The stationary office ; 2008. p. 663 and 1805.

Gupta D, Sharma SC. Oral submucous fibrosis - A new treatment regimen. J Oral Maxillofacial Surg. 1988;46(10):830-33.

Gupta J, Srinivasan SV, Daniel MJ. Efficacy of betamethasone, placental extract and hyaluronidase in treatment of OSMF: A comparative study. E-J Dent. 2012;2(1):132-35.

Hamishehkar H, Nokhodchi A,Ghanbarzadeh S, Kaunsoltani M. Triamcinolone acetonide oro mucoadhesive paste for treatment of apthous stomatitis. Adv Pharm Bull. 2015;5(2):277-82.

Hanan K, Lena V, Saba AJ. Development and physical characterization of a perodental bioadhesive gel of gatifloxacin. Int J App Pharm. 2018;9(3):31-6.

James L, Shetty A, Rishi D, Abraham M. Management of OSMF with injection of hyaluronidase and dexamethasone in grade III OSMF. A retrospective study. J Int Oral Health. 2015;7(8):82-5.

Jones DS, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm. 1997;151(2):223-33.

Jones DS, Woolfson AD, Djokic J. Texture profile analysis of bioadhesive polymeric semisolids: Mechanical characterization and investigation of interactions between formulation components. J Appl Polym Sci. 1996;61(12):2229-34.

Kaja S, Payne AJ, Naumchuk Y, Koulen P. Quantification of lactate dehydrogenase for cell viability testing using cell lines and primary cultured astrocytes. Curr Protoc Toxicol. 2017;72:1-10.

Krishnamoorthy B, Khan M. Management of 0SMF by two different drug regimens: A comparative study. Dent Res J. 2013;10(4):527-32.

Kumar KK, Saraswathi TR, Ranganathan K, Umadevi M, Elizabeth J. Oral submucous fibrosis: A clinico-histopathological study in Chennai. Indian J Dent Res. 2007;18(3):106-11.

Kumar L, Verma R. Chemical stability studies of bioadhesive topical gel. Int J Pharm Pharm Sci. 2010;3(1):101-4.

Manavalan, Ramsay. Rheological behavior of pseudoplastic materials. Physical pharmaceutics. 2nd ed. Chennai: Vignesh publisher. 2006. p. 103-6.

Mastan KMK, Aravindha Babu N, Jha A, Elumalai M. Steroidal application in oral diseases. Int J Pharm Bio Sci. 2013;4(2):829-34.

More CB, Shah PH, Rao NR, Powar RK. OSMF: An overview with evidence based management. Int J Oral Health Sci Adv. 2015;3:40-9.

Nair U, Bartsch H, Nair J. Alert for an epidermic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanism. Mutagenesis. 2004;19(4):251-62.

Pandit JK, Bharathi D, Srinatha A, Ridhurkar DN, Singh S. Long acting ophthalmic formulation of indomethacin: evaluation of alginate gel systems. Ind J Pharm Sci. 2007;69(1):37-40.

Patel AB, Gondkar SB, Soudagar RB. Design and evaluation of mucoadhesive gel of glimepiride for nasal delivery, Am J Pharm Health Res. 2013;1(5):67-77.

Pillai R, Balaram P, Reddiar KS. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer. Cancer. 1992;69(8):2011-20.

Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 1966;22(6):764-79.

Polshettiwar S, Valvi S, Baheti A, Kuchekar BS. Design, development and evaluation of buccal mucoadhesive patch of dexamethasone sodium phosphate for the management of OSMF, ulceration and lichen plantus. Indo Am J Pharm Res. 2019;9(7):3081-94.

Rajalalitha P,Vali S. Molecular pathogenesis of OSMF. J Oral Pathol Med. 2005;34(6):241-8.

Shah PH, Venkatesh R, More CB, Vassandacoumara V. Comparision of therapeutic efficacy of placental extract with dexamethasone and hyaluronic acid with dexamethasone for oral submucous fibrosis- A retrospective analysis. J Clin Diagn Res. 2016;10(10):63-6.

Shah RA, Mehta MR, Patel DM. Design and optimization of mucoadhesive nasal in situ gel containing sodium cromoglycate using factorial design. Asian J Pharm. 2011;5(2):65-74.

Sherafudeen S, Vasantha PV. Development and evaluation on insitu nasal gel formulations of loratadine. Res Pharm Sci. 2015;10(6):466-76.

Shukr MH, Metwally GF. Evaluation of topical gel bases formulated with various essential oils for antibacterial activity against methicillin-resistant Staphylococcus aureus Trop J Pharm Res. 2013;12(6):877-84.

Singh D, Shashikanth MC, Mishra N, Agarwal S. Lycopene and intralesional betamethasone injection in the management of OSMF. J Indian Acad Oral Med Radiol. 2014;26(3):264-8.

Singh P, Gharote H, Nair P, Hegde K, Saawran N, Guruprasad R. Evaluation of cachexia in oral submucous fibrosis. J Indian Acad Oral Med Radiol. 2012;24(2):130-2.

Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FSA case study of OSMF with special reference to etiological role of areca nut. J Oral Pathol Med . 1990;19(2):94-8.

Sneh P, Ratnand M, Udupa N, Ongole R, Sumanth KN, Joshi V. Preparation and evaluation of buccal mucoadhesive patch of betamethasone sodium phosphate for the treatment of OSMF. J Chem Pharm Res. 2011;3(6):56-65.

Sores AB, Perschbacher K, Ordonez BP. Oral potentially malignant disorders. Diagn Histopathol. 2018;24(5):161-65.

Surampalli G, Nanjwade B, Patil PA. Comprehensive cytotoxic evaluation of morin, a bioflavonoid against verapamil on rat gastrointestinal epithelium for novel pharmaceutical application involving P-glycoprotein inhibition. J Pharm Pharmacol. 2015;67(8):1083-99.

Suresh PK, Manhar S. Bioadhesive buccal gels impregnated with fluconazole: formulation, in vitro and ex vivo characterization. J Appl Pharm Sci. 2014;4(3):15-9.

Tanwar YS, Jain K. Formulation and evaluation of topical diclofenac sodium gel using different gelling agent. Asian J Pharm Res Health Care. 2012;4(1):1-6.

Thakur N, Keluskar V, Bagewadi A, Shetti A. Effectiveness of micronutrients and physiotherapy in management of OSMF. Int J Contemp Dent. 2011;2(1):101-5.

Tilakratne WM, Klinikowski MF, Saku T, Peteres TJ, Warnakulasuriya S. OSMF: Review on aetiology and pathogenesis. Oral Oncol. 2006;42(6):561-68.

Wahi PN, Luthra UK, Kapur VL. Submucous fibrosis of oral cavity-Histomorphological studies. Br J Cancer. 1966;20(4):676-87.

Wen QT, Wang T, Yu DH, Wang ZR, Sun Y, Liang CW. Development of a mouse model of arecoline-induced oral mucosal fibrosis. Asian Pac J Trop Med. 2017;10(12):1177-84.

Yan J, Chen X, Shuying YU, Zhou H. Comparison of different in vitro mucoadhesion testing methods for hydrogels. J Drug Deliv Sci Tech. 2017;40:157-63.

Yajaman S, Ketousetuo K, Bandyopadhyay AK. Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs. J Cont Rel. 2006;114(1):15-40.

Zhang SS, Gong ZJ, Xiong W, Wang X, Min Q. A rat model of oral submucous fibrosis induced by bleomycin. J Oral Med Oral Surg OPathol Oral Radiol. 2016;122(2):216-23.

Published

2022-12-23

Issue

Section

Original Article

How to Cite

A comparative physicochemical and pharmacological evaluation of dexamethasone sodium phosphate and betamethasone sodium phosphate mucoadhesive gels for the treatment of oral submucous fibrosis in rats. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e20262